Zhigang Zhao

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Cell Cycle Arrest

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Wenqi Wu, Yanan Jiang, Donghui Xing, Yixin Zhai, Huimeng Sun, Xiang He, Kaiping Luo, Pengpeng Xu, Feng Pan, Guolei Dong, Guibing Ren, Zhigang Zhao
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia. Cell death discovery 10 (1) (2024)
Wenqi Wu, Yanan Jiang, Donghui Xing, Yixin Zhai, Huimeng Sun, Xiang He, Kaiping Luo, Pengpeng Xu, Feng Pan, Guolei Dong, Guibing Ren, Zhigang Zhao
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia. Cell death discovery 10 (1) (2024)
Wenqi Wu, Yanan Jiang, Donghui Xing, Yixin Zhai, Huimeng Sun, Xiang He, Kaiping Luo, Pengpeng Xu, Feng Pan, Guolei Dong, Guibing Ren, Zhigang Zhao
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia. Cell death discovery 10 (1) (2024)
Jing Guo, Yangyang Lv, Sheng Wang, Ziyi Peng, Ying Xie, Yixuan Wang, Hongmei Jiang, Xin Li, Mengqi Wang, Meilin Hu, Jiangpeng Mu, Jingya Wang, Yangyang Xie, Xiankui Cheng, Zhigang Zhao, Zhiqiang Liu
Hypoxia induces chemoresistance to proteasome inhibitors through orchestrating deSUMOylation and ubiquitination of SRC-3 in multiple myeloma. Oncogene 41 (45) (2022)